ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. ResMed Inc. is placed fourth among them.

ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care solutions. The company develops innovative devices and digital platforms that support patients with sleep apnea, chronic respiratory conditions, and related disorders, combining medical expertise with advanced technology to improve patient outcomes globally.

In 2025, ResMed Inc. (NYSE:RMD) launched its Sleep Institute, unveiled at the World Sleep Congress, aiming to advance sleep health through partnerships with clinicians, researchers, policymakers, and health system leaders. The initiative focuses on delivering evidence-based insights to drive care innovation and inform policy, addressing the massive global burden of sleep disorders like obstructive sleep apnea (OSA) and insomnia, which remain largely undiagnosed.

The business also highlighted research at the SLEEP 2025 conference, emphasizing trends such as PAP therapy adherence, gender disparities in OSA diagnosis, patient-reported outcomes, and the role of artificial intelligence in enhancing therapy engagement. These developments position RMD as one of the hot stocks to buy in the health technology sector, reflecting its strong growth potential through innovation in both devices and digital health solutions.

Further expanding its capabilities, ResMed Inc. (NYSE:RMD) acquired VirtuOx, an independent diagnostic testing facility specializing in at-home diagnostics for sleep, respiratory, and cardiac conditions. This acquisition strengthens RMD’s ability to provide early diagnosis and connected home-based care, simplifying patient access while supporting better health outcomes.

While we acknowledge the potential of RMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure. None.